CHCWM – Cancer & Hematology Centers of West Michigan

R7075-ONC-1933 (Regeneron)

A Phase 1/2 Study of REGN7075 (EGFRxCD28 Costimulatory Bispecific Antibody) in Combination with Cemiplimab in Patients with Advanced Solid Tumors